Trius Therapeutics (TSRX)

Latest Trade:   $7.95
$7.95
IPO News
IPO Performance
  • 0.0%
  • 59.0%
  • 59.0%
IPO Profile
  • 08/02/10
  • $5.00
  • 10.0 mm
  • *Previously postponed on 3/1/2010 due to modification of its Ph. 3 trials, refiled amendment on 6/16/2010.
  • Citi
    Piper Jaffray
  • Canaccord Genuity

  • All Underwriters
Business
  • Developing an antibiotic for serious gram-positive Staph infections.
  • Health-Biotech
  • 36
  • 2004
TSRX Daily
 
Corporate Data
  • 6310 Nancy Ridge Drive, Suite 101
    San Diego, CA
  • 858-452-0370
  • www.triusrx.com